title: Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
abstract: Noroviruses are the primary cause of epidemic gastroenteritis in humans, and GII.4 strains cause ∼80% of the overall disease burden. Surrogate neutralization assays using sera and mouse monoclonal antibodies (MAbs) suggest that antigenic variation maintains GII.4 persistence in the face of herd immunity, as the emergence of new pandemic strains is accompanied by newly evolved neutralization epitopes. To potentially identify specific blockade epitopes that are likely neutralizing and evolving between pandemic strains, mice were hyperimmunized with GII.4-2002 virus-like particles (VLPs) and the resulting MAbs were characterized by biochemical and immunologic assays. All of the MAbs but one recognized GII.4 VLPs representing strains circulating from 1987 to 2009. One MAb weakly recognized GII.4-1987 and -1997 while strongly interacting with 2002 VLPs. This antibody was highly selective and effective at blocking only GII.4-2002-ligand binding. Using bioinformatic analyses, we predicted an evolving GII.4 surface epitope composed of amino acids 407, 412, and 413 and subsequently built mutant VLPs to test the impact of the epitope on MAb binding and blockade potential. Replacement of the 2002 epitope with the epitopes found in 1987 or 2006 strains either reduced or ablated enzyme immunoassay recognition by the GII.4-2002-specific blockade MAb. These data identify a novel, evolving blockade epitope that may be associated with protective immunity, providing further support for the hypotheses that GII.4 norovirus evolution results in antigenic variation that allows the virus to escape from protective herd immunity, resulting in new epidemic strains.
authors.affiliation: Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, USA.
authors.forename: Lisa C
authors.initials: LC
authors.lastname: Lindesmith
authors.forename: Kari
authors.initials: K
authors.lastname: Debbink
authors.forename: Jesica
authors.initials: J
authors.lastname: Swanstrom
authors.forename: Jan
authors.initials: J
authors.lastname: Vinjé
authors.forename: Verónica
authors.initials: V
authors.lastname: Costantini
authors.forename: Ralph S
authors.initials: RS
authors.lastname: Baric
authors.forename: Eric F
authors.initials: EF
authors.lastname: Donaldson
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000914:Antibodies, Viral / Q000276:immunology*; D000940:Antigenic Variation; D005075:Biological Evolution; D017250:Caliciviridae Infections / Q000276:immunology / Q000821:virology*; D036022:Capsid Proteins / Q000235:genetics / Q000276:immunology; D018604:Epitope Mapping / Q000295:instrumentation / Q000379:methods*; D005759:Gastroenteritis / Q000276:immunology / Q000821:virology; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D029322:Norovirus / Q000235:genetics / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D036022:Capsid Proteins
references.citation: J Virol. 2010 Feb;84(4):1800-15
references.pmid: 20007270
references.citation: MMWR Morb Mortal Wkly Rep. 2007 Aug 24;56(33):842-6
references.pmid: 17717513
references.citation: J Virol. 2011 Jan;85(1):231-42
references.pmid: 20980508
references.citation: Nat Med. 2003 May;9(5):548-53
references.pmid: 12692541
references.citation: Nat Rev Microbiol. 2010 Mar;8(3):231-41
references.pmid: 20125087
references.citation: PLoS One. 2008 Jan 23;3(1):e1485
references.pmid: 18213393
references.citation: J Virol. 2007 Nov;81(22):12316-22
references.pmid: 17804495
references.citation: Res Vet Sci. 2007 Dec;83(3):410-8
references.pmid: 17379264
references.citation: J Infect Dis. 2005 Sep 15;192(6):1071-7
references.pmid: 16107962
references.citation: J Virol. 2011 May;85(9):4057-70
references.pmid: 21345963
references.citation: J Virol. 2002 Mar;76(6):3023-30
references.pmid: 11861868
references.citation: Arch Virol. 2006 Aug;151(8):1635-41
references.pmid: 16521046
references.citation: J Virol. 2007 Sep;81(18):9932-41
references.pmid: 17609280
references.citation: Euro Surveill. 2008 Jan 10;13(2):
references.pmid: 18445388
references.citation: J Virol. 2011 Sep;85(17):8635-45
references.pmid: 21715503
references.citation: Emerg Infect Dis. 2008 Aug;14(8):1224-31
references.pmid: 18680645
references.citation: J Virol. 2007 Jun;81(11):5949-57
references.pmid: 17392366
references.citation: J Virol. 2009 Nov;83(22):11890-901
references.pmid: 19759138
references.citation: PLoS Pathog. 2011 Jul;7(7):e1002152
references.pmid: 21811409
references.citation: J Virol. 2012 Jan;86(2):1214-26
references.pmid: 22090110
references.citation: Trends Microbiol. 2004 Jun;12(6):279-87
references.pmid: 15165606
references.citation: J Infect Dis. 1997 Nov;176(5):1374-8
references.pmid: 9359742
references.citation: J Infect Dis. 2004 Jul 1;190(1):27-36
references.pmid: 15195240
references.citation: Clin Infect Dis. 2010 Aug 1;51(3):307-14
references.pmid: 20575662
references.citation: Science. 1999 Oct 8;286(5438):287-90
references.pmid: 10514371
references.citation: PLoS Pathog. 2010 Mar 26;6(3):e1000831
references.pmid: 20360972
references.citation: J Virol. 2002 Dec;76(23):12335-43
references.pmid: 12414974
references.citation: Nucleic Acids Res. 2003 Jul 1;31(13):3497-500
references.pmid: 12824352
references.citation: J Gen Virol. 2005 Oct;86(Pt 10):2799-2806
references.pmid: 16186235
references.citation: Immunol Rev. 2008 Oct;225:190-211
references.pmid: 18837783
references.citation: J Infect Dis. 2000 May;181 Suppl 2:S262-9
references.pmid: 10804135
references.citation: J Infect Dis. 2002 Jul 1;186(1):1-7
references.pmid: 12089655
references.citation: J Med Virol. 2006 Jul;78(7):971-8
references.pmid: 16721850
references.citation: Virology. 2006 Mar 15;346(2):312-23
references.pmid: 16343580
references.citation: J Infect Dis. 1999 Jun;179(6):1334-44
references.pmid: 10228052
references.citation: J Appl Microbiol. 2010 Nov;109(5):1753-62
references.pmid: 21040268
references.citation: J Virol. 1992 Nov;66(11):6527-32
references.pmid: 1328679
references.citation: J Clin Microbiol. 2006 Feb;44(2):327-33
references.pmid: 16455879
references.citation: J Virol. 2006 Nov;80(21):10372-81
references.pmid: 17041218
references.citation: Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):325-30
references.pmid: 21173246
references.citation: Curr Opin Infect Dis. 2006 Oct;19(5):467-74
references.pmid: 16940871
references.citation: Emerg Infect Dis. 2008 Oct;14(10):1546-52
references.pmid: 18826817
references.citation: J Infect Dis. 2010 Oct 15;202(8):1212-8
references.pmid: 20815703
references.citation: Vaccine. 2006 Jun 12;24(24):5220-34
references.pmid: 16650512
references.citation: Euro Surveill. 2006 Dec 14;11(12):E061214.1
references.pmid: 17213565
references.citation: Proc Natl Acad Sci U S A. 2006 May 23;103(21):8048-53
references.pmid: 16702551
references.citation: PLoS Med. 2008 Feb;5(2):e31
references.pmid: 18271619
references.citation: J Virol. 2010 Sep;84(18):9595-607
references.pmid: 20592096
references.citation: MMWR Recomm Rep. 2011 Mar 4;60(RR-3):1-18
references.pmid: 21368741
references.citation: J Virol. 2009 Jun;83(11):5363-74
references.pmid: 19297483